CELU: celularity.com Company Value to Net Income
The price action for Celularity Inc. (CELU) on the GURU.Markets platform is recorded at -0.50. Celularity Inc. faces a potential liquidity shortage due to the high costs of biomaterial testing. The business relies on developing scalable, high-yield cellular products. Leading biology specialists aiming to combat aging and oncology drive the project's success.
%20P%2FE%20Multiple&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CELU_-_Celularity-Inc._-_PE-Multiple "CELU: Celularity Corp Business Payback Period 07/04/2022 - 11/10/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Celularity Inc (CELU)
- price and consensus price forecast:
- market capitalization information:
- balance sheet net asset value indicators:
- debt and solvency information:
- earnings and market multiples details:
CELU - Net Profit|Expected Net Profit Celularity Inc.|CELU - Price to Earnings Ratio|Future Price to Earnings Celularity Corp|CELU - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Celularity Inc.|CELU - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Celularity|CELU - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth celularity.com|CELU - Earnings per share growth in current year|Expected earnings per share trend next year Celularity Inc.
Comprehensive company analysis:celularity.com CELU
The P/E ratio reflects the market value of the business relative to its annual net income, measuring the investment payback period based on current earnings trends. A P/E analysis of the financial statements allows for an assessment of market expectations regarding the scaling of Celularity Inc. (CELU) proprietary stem cell technology for the creation of universal immunotherapeutic drugs without the need for donor matching.
Key competitors
P/E Multiple argenx.com|Price to Earnings Ratio BNTX (BioNTech)|ABVX (ABIVAX) - Company Value to Net Income|P/E Multiple ADMA (ADMA Bio)|Business Payback Period Protagonist Corp (PTGX)|IMVT - Price to Earnings Ratio|kiniksa.com (KNSA) - Price to Earnings Ratio|Grifols (GRFS) - Price to Earnings Ratio|Price to Earnings Ratio Adaptive Biotech|Price to Earnings Ratio CLDX|P/E Multiple Aurinia Corp|Price to Earnings Ratio BioCryst (BCRX)|veratx.com - Price to Earnings Multiple|P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Market Cap to Earnings|AbCellera Bio - P/E Multiple|Tourmaline (TRML) - Price to Earnings Ratio|PGEN: P/E Multiple|Market Cap to Earnings pharming.com (PHAR)|Price to Earnings Ratio Nektar Therapeutics Inc.|Price to Earnings Ratio UPB|Price to Earnings Ratio ZBIO (Zenas Biopharma, Inc.)|P/E Multiple Immunome Bio (IMNM)|Price to Earnings Ratio Gossamer Bio, Inc. GOSS|kalvista.com - Price to Earnings Ratio|Septerna - P/E Multiple|PVLA - P/E Multiple|Savara Corp (SVRA) - Price to Earnings Ratio|Rigel Corp - Company Value to Net Income|ANAB (AnaptysBio, Inc.) - P/E Multiple|astriatx.com (ATXS) - Business Payback Period|Price to Earnings Ratio ENGN (enGene)|Market Price to Net Income Ratio RAPT|Aerovate Therapeutics - Price to Earnings Ratio|Aclaris Therapeutics, Inc (ACRS) - Market Cap to Earnings|KYTX: Price to Earnings Ratio|Company Value to Net Income TLSA (tizianalifesciences.com)|CABA: P/E Multiple|VTYX - Business Payback Period|Price to Earnings Ratio Theratechnologies Inc|Price to Earnings Multiple AVTX (Avalo Therapeutics Inc)|P/E Multiple ELDN|Price to Earnings Ratio agenusbio.com AGEN|Climb Bio - Price to Earnings Ratio|Business Payback Period Zura Bio Ltd (ZURA)|aTyr - P/E Multiple|Adagene (ADAG) - Price to Earnings Ratio|IMA: P/E Multiple|Market Cap to Earnings Shattuck Labs (STTK)|Price to Earnings Ratio Equillium Inc|Price to Earnings Ratio CNTB|Price to Earnings Ratio IMUX (Immunic, Inc.)|P/E Multiple atarabio.com (ATRA)|Price to Earnings Ratio InflaRx IFRX|XFOR (x4pharma.com) - Market Cap to Net Income|Adicet - P/E Multiple|Company Value to Net Income INMB (INmune Bio Inc)|BRNS: P/E Multiple|Kezar Life Sciences Inc (KZR) - P/E Multiple|Price to Earnings Ratio SAB Biotherapeutics|AKTX: Company Value to Net Income|Price to Earnings Ratio Enlivex Therapeutics (ENLV)|Price to Earnings Ratio q32bio.com QTTB|P/E Multiple GOVX (GeoVax Labs Inc)|P/E Multiple Edesa Biotech Corp EDSA|IBIO: Price to Earnings Ratio|Company Value to Net Income CARM (Carisma Therapeutics)|XTLB: P/E Multiple|BOLT - Business Payback Period|Price to Earnings Ratio HCW Biologics, Inc.|Price to Earnings Ratio Aptevo (APVO)|Price to Earnings Ratio AIM ImmunoTech Inc. (AIM)|Price to Earnings Ratio aditxt.com ADTX|GRI Bio - Price to Earnings Ratio|P/E Multiple XORTX Therapeutics Inc XRTX|HIND - Price to Earnings Ratio|REVB (Revelation Biosciences Corp) - Price to Earnings Multiple|INDP: P/E Multiple|Market Cap to Earnings scinai.com (SCNI)|CALI (CalciMedica Inc) - P/E Multiple|Price to Earnings Ratio Affimed Therapeutics (AFMD)|P/E Multiple ALLK|HOOK - Market Cap to Earnings|Price to Earnings Ratio IGM Biosciences IGMS|iteostherapeutics.com - Price to Earnings Ratio|OCEA: Price to Earnings Ratio|TCBP - P/E Multiple|Third Harmonic Bio, Inc (THRD) - Price to Earnings Ratio
